Form 4: KORU Medical Systems Director Receives Stock Grant for Board Service

Joseph M. Manko Jr., a director of KORU Medical Systems, received 3,937 shares of common stock for his board service during the quarter ended December 31, 2024, while Horton Capital Partners Fund, LP, disposed of 165,252 shares.

Summary

• On December 31, 2024, Horton Capital Partners Fund, LP (HCPF) was granted 3,937 shares of Koru Medical Systems, Inc. common stock in consideration for Joseph M. Manko Jr.'s service as a director for the quarter ended December 31, 2024.
• Following the transaction, Mr. Manko indirectly owns 6,887,864 shares through Horton Capital Partners Fund, LP.
• Horton Capital Management, LLC (HCM) maintains investment and voting power over these shares through investment advisory agreements.
• Horton Capital Partners, LLC (HCP) may also be deemed a beneficial owner due to its right to assume HCM's authority if the advisory agreement is terminated.
• HCP is the general partner of HCPF, and Mr. Manko is the managing member of both HCM and HCP.
• The reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing, so the sentiment is neutral. It reports a stock grant and a disposal of shares, which are routine transactions.

Positives

• The stock grant to the director aligns his interests with the company's performance.

Negatives

• Horton Capital Partners Fund, LP, disposed of 165,252 shares of common stock.

Management Comments

• Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.

Stakeholder Impact

• Shareholders may be interested in the insider transactions reported in this filing.

Key Dates